Search Results - D. Vishwamitra

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    P30 SINGLE COHORT RESULTS FROM MAJESTEC-2: TECLISTAMAB (TEC) IN COMBINATION WITH SUBCUTANEOUS DARATUMUMAB (DARA) AND LENALIDOMIDE (LEN) IN PATIENTS WITH MULTIPLE MYELOMA (MM) by E. Searle, H. Quach, S. Wong, L. Costa, C. Hulin, W. Janowski, J. Berdeja, S. Anguille, J. Matous, C. Touzeau, A. Michallet, M. Husnik, D. Vishwamitra, Z. Niu, J. Larsen, L. Chen, J. Goldberg, R. Popat, A. Spencer

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  2. 2

    S182: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FR... by M. C. Minnema, A. Krishnan, J. G. Berdeja, A. Oriol, N. W. van de Donk, P. Rodríguez-Otero, D. Morillo, M.-V. Mateos, L. J. Costa, J. Caers, D. Vishwamitra, J. Ma, S. Yang, B. W. Hilder, J. Tolbert, J. D. Goldberg, A. Chari

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS by P. Rodriguez Otero, A. D’Souza, D. Reece, N. W. van de Donk, A. Chari, A. Krishnan, T. Martin, M. V. Mateos, D. Morillo, D. Hurd, L. Rosinol, A. S. Balari, R. Wäsch, D. Vishwamitra, S. X. Wang Lin, T. Prior, L. Vandenberk, M.-A. D. Smit, A. Oriol, B. Dholaria

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) by N. van de Donk, D. Cortes-Selva, T. Casneuf, D. Vishwamitra, S. Stein, T. Perova, E. Ramos, L. Van Steenbergen, R. Boominathan, O. Lau, C. Davis, A. Banerjee, T. Stephenson, C. Uhlar, R. Kobos, J. Goldberg, L. Pei, D. Trancucci, S. Girgis, S.X.W. Lin, L.S. Wu, P. Moreau, S. Usmani, N.J. Bahlis, R. Verona

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  5. 5

    P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)... by M.C. Minnema, A. Chari, C. Touzeau, C. Schinke, J. Berdeja, A. Oriol, de Donk N. van, P.R. Otero, E. Askari, M.V. Mateos, L.J. Costa, J. Caers, L. Rasche, A. Krishnan, D. Vishwamitra, X. Ma, X. Qin, K.S. Gries, M. Campagna, T. Masterson, B. Hilder, J. Tolbert, T. Renaud, J.D. Goldberg, C. Heuck, J.S. Miguel, P. Moreau

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  6. 6

    P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISP... by N. van de Donk, L. Rasche, C. Touzeau, A. Chari, C. Schinke, M. Minnema, J. Berdeja, A. Oriol, P. Rodriguez-Otero, E. Askari, M. Mateos, L. Costa, J. Caers, A. Krishnan, D. Vishwamitra, J. Ma, X. Qin, K.S. Gries, K. Kato, M. Campagna, T. Masterson, B. Hilder, J. Tolbert, T. Renaud, J. Goldberg, C. Heuck, P. Moreau, J. San-Miguel

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  7. 7

    S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN CO... by N. W. van de Donk, N. Bahlis, M.-V. Mateos, K. Weisel, B. Dholaria, A. L. Garfall, H. Goldschmidt, T. G. Martin, D. Morillo, D. E. Reece, D. Hurd, P. Rodríguez-Otero, M. Bhutani, A. D’Souza, A. Oriol, E. Askari, J. F. San-Miguel, K. M. Kortüm, D. Vishwamitra, S. Xin Wang Lin, T. J. Prior, L. Vandenberk, M.-A. D. Smit, J. D. Goldberg, R. Wäsch, A. Chari

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: